-
Esperion Therapeutics' (ESPR) Market Outperform Rating Reaffirmed at JMP Securities
ソース: Buzz FX / 11 2 2025 11:16:12 America/New_York
Esperion Therapeutics' (ESPR) Market Outperform Rating Reaffirmed at JMP Securities Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "market out
Read more...